During the past decade, Bozeman Deaconess Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 109 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 13 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bozeman Deaconess Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 57 trials, followed by "SWOG Cancer Research Network" with 53 trials sponsored, "National Cancer Institute (NCI)" with 26 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "NSABP Foundation Inc" with 7 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bozeman Deaconess Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 135 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "Eastern Cooperative Oncology Group" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Bozeman Deaconess Cancer Center" are "Breast Cancer" (30 trials), "Lung Cancer" (19 trials), "Lymphoma" (16 trials), "Leukemia" (11 trials) and "Prostate Cancer" (10 trials). Many other conditions were trialed in "Bozeman Deaconess Cancer Center" in a lesser frequency.

Most popular intervention types in "Bozeman Deaconess Cancer Center" are "Drug" (128 trials), "Other" (55 trials), "Biological" (51 trials), "Radiation" (23 trials) and "Procedure" (19 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (26 trials), "cyclophosphamide" (17 trials), "bevacizumab" (15 trials), "rituximab" (12 trials) and "radiation therapy" (11 trials). Other intervention names were less common.

The vast majority of trials in "Bozeman Deaconess Cancer Center" are 128 trials for "All" genders, 23 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Bozeman Deaconess Cancer Center". undefined are not yet recruiting, undefined are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 123 completed trials in Bozeman Deaconess Cancer Center, undefined suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Bozeman Deaconess Cancer Center, 6 "Phase 1" clinical trials were conducted, 86 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".